The placebo effect in allergen-specific immunotherapy trials

BACKGROUND: Double-blind, placebo-controlled (DBPC) trials are the gold standard for demonstrating clinical efficacy and tolerability. The placebo effect, although an important feature in placebo-controlled studies, has never been systematically investigated in allergen-specific immunotherapy (SIT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Narkus, Annemie, Lehnigk, Ulrike, Haefner, Dietrich, Klinger, Regine, Pfaar, Oliver, Worm, Margitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878370/
https://www.ncbi.nlm.nih.gov/pubmed/24360060
http://dx.doi.org/10.1186/2045-7022-3-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878370/
https://www.ncbi.nlm.nih.gov/pubmed/24360060
http://dx.doi.org/10.1186/2045-7022-3-42

Ejemplares similares